BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20229896)

  • 41. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
    Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
    Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-water calibration of PDR 192Ir brachytherapy sources with an NE2571 ionization chamber.
    Reynaert N; Verhaegen F; Thierens H
    Phys Med Biol; 1998 Aug; 43(8):2095-107. PubMed ID: 9725592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV:EGS4 Monte Carlo model calculation.
    Luxton G; Jozsef G
    Med Phys; 1999 Dec; 26(12):2531-8. PubMed ID: 10619236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study.
    Price MJ; Horton JL; Gifford KA; Eifel PJ; Jhingran A; Lawyer AA; Berner PA; Mourtada F
    Phys Med Biol; 2005 Nov; 50(21):5075-87. PubMed ID: 16237242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
    Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
    Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Air kerma rate constants for gamma emitters used most often in practice.
    Ninkovic MM; Raicevic JJ; Adrovic F
    Radiat Prot Dosimetry; 2005; 115(1-4):247-50. PubMed ID: 16381721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monte Carlo dosimetry of the VariSource high dose rate 192Ir source.
    Wang R; Sloboda RS
    Med Phys; 1998 Apr; 25(4):415-23. PubMed ID: 9571607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of ambient pressure on well chamber response: Monte Carlo calculated results for the HDR 1000 plus.
    Bohm TD; Griffin SL; DeLuca PM; DeWerd LA
    Med Phys; 2005 Apr; 32(4):1103-14. PubMed ID: 15895595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variations in energy spectra and water-to-material stopping-power ratios in three-dimensional conformal and intensity-modulated photon fields.
    Jang SY; Liu HH; Mohan R; Siebers JV
    Med Phys; 2007 Apr; 34(4):1388-97. PubMed ID: 17500470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of dosimetric parameters for various 192Ir brachytherapy sources under unbounded phantom geometry by Monte Carlo simulation.
    Devan K; Aruna P; Manigandan D; Bharanidharan G; Subbaiah KV; Sunny CS; Ganesan S
    Med Dosim; 2007; 32(4):305-15. PubMed ID: 17980833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of TG-43 dosimetric parameters of brachytherapy sources obtained by three different versions of MCNP codes.
    Zaker N; Zehtabian M; Sina S; Koontz C; Meigooni AS
    J Appl Clin Med Phys; 2016 Mar; 17(2):379-390. PubMed ID: 27074460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photon activation therapy: a Monte Carlo study on dose enhancement by various sources and activation media.
    Bakhshabadi M; Ghorbani M; Meigooni AS
    Australas Phys Eng Sci Med; 2013 Sep; 36(3):301-11. PubMed ID: 23934379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
    Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
    Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of air-kerma strength for the 192Ir GammaMedplus iX pulsed-dose-rate brachytherapy source.
    Riley AD; Pike TL; Micka JA; Fulkerson RK; DeWerd LA
    Med Phys; 2013 Jul; 40(7):071732. PubMed ID: 23822436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absolute depth-dose-rate measurements for an 192Ir HDR brachytherapy source in water using MOSFET detectors.
    Zilio VO; Joneja OP; Popowski Y; Rosenfeld A; Chawla R
    Med Phys; 2006 Jun; 33(6):1532-9. PubMed ID: 16872060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.